Ahuja Nita 4

What Happened Nita Ahuja, a director of Abbott Laboratories (ABT), was granted 347 shares as a derivative award on 2026-06-30. The award is reported at a per-share value of $90.74, totaling $31,487. This was an acquisition via a stock-equivalent award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-30; Report filed: 2026-07-01 (appears timely).
• Award: 347 shares × $90.74 per share = $31,487 (derivative stock-equivalent units).
• Shares owned after transaction: not specifically quantified in the filing.
• Footnotes: F1 — Director fees are credited to a stock-equivalent unit account and paid in cash generally at age 65 or upon retirement; units track Abbott share returns. F2 — Balance includes stock-equivalent units from a dividend reinvestment feature.
• No 10b5‑1 plan, tax withholding, or sale noted in this filing.

Context This was a compensation-related stock-equivalent award (derivative units) typical for non-employee directors and does not represent an open-market buy or sell. These units track Abbott’s stock performance and are generally paid in cash upon certain retirement/age conditions, so they are more a form of deferred pay than an immediate equity stake purchase.